Jazz Pharmaceuticals
JAZZ
$109.46
Share price
1.89%
Change (1 day)
-22.47%
Change (1 year)
Categories
Jazz Pharmaceuticals (JAZZ) - Cash on Hand
Cash on Hand as of December 2023 : $1.62 B
According to Jazz Pharmaceuticals's latest financial reports the company has $1.62 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Jazz Pharmaceuticals - Cash on Hand chart (from 2005 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $1.62 B | 84.5% |
| 2022-12-31 | $0.88 B | 49.04% |
| 2021-12-31 | $0.59 B | -72.27% |
| 2020-12-31 | $2.13 B | 97.97% |
| 2019-12-31 | $1.07 B | 30.65% |
| 2018-12-31 | $0.82 B | 37.2% |
| 2017-12-31 | $0.60 B | 41.1% |
| 2016-12-31 | $0.42 B | -56.92% |
| 2015-12-31 | $0.98 B | 44.55% |
| 2014-12-31 | $0.68 B | 7.47% |
| 2013-12-31 | $0.63 B | 64.39% |
| 2012-12-31 | $0.38 B | 145.22% |
| 2011-12-31 | $0.15 B | 252.5% |
| 2010-12-31 | $44.79 M | 187.23% |
| 2009-12-31 | $15.59 M | -39.8% |
| 2008-12-31 | $25.9 M | -74.83% |
| 2007-12-31 | $0.10 B | 30.4% |
| 2006-12-31 | $78.94 M | 282.98% |
| 2005-12-31 | $20.61 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $13.96 B | 758.51% | 🇨🇭 Switzerland |
 AmerisourceBergen
ABC | $1.38 B | -14.57% | 🇺🇸 USA |
 Endo International
ENDPQ | $0.77 B | -52.17% | 🇮🇪 Ireland |
 Teva Pharmaceutical Industries TEVA | $3.22 B | 98.36% | 🇮🇱 Israel |